Omzo vs Yucca Health: Clinician-Guided Care vs Low Prices
Comparing Omzo vs Yucca Health quickly: Yucca Health generally undercuts Omzo on price and promotes fast 24-hour approvals and 2-day shipping, while Omzo emphasizes clinician-guided plans and the option for providers to prescribe branded medications or compounded semaglutide, with compounded drugs noted as not FDA-approved. Early verdict: choose Yucca Health for lower starting monthly cost and rapid processing; choose Omzo if you want clinician-reviewed plans with the potential option of branded prescriptions through your own pharmacy.
See Omzo clinician-guided plans
Key differences at a glance in Omzo vs Yucca Health
This comparison focuses on the most distinctive supported differences: pricing and payment options, medication sourcing and regulatory notes, clinician and state coverage details, approval and shipping speed, and treatment options available.
1. Price and payment structure
Yucca Health lists compounded semaglutide from $146/month and tirzepatide from $258/month and promotes multi month plans such as a 6-month semaglutide plan at $875. Omzo lists semaglutide starting at $179 and tirzepatide starting at $279. Yucca Health also advertises Buy Now Pay Later via Klarna, Afterpay, and Affirm. Both providers require direct payment; Yucca Health states it does not accept insurance and Omzo notes users are responsible for filling branded prescriptions at their chosen pharmacy when prescribed.
View Yucca Health pricing and plans
2. Medication sourcing and regulatory notes
Both platforms offer compounded semaglutide and tirzepatide options prepared by compounding pharmacies. Omzo explicitly states its compounded medications are prepared and shipped by a state licensed sterile compounding pharmacy and that compounded drugs are not FDA-approved. Yucca Health similarly notes compounded medications are not FDA-approved and are prepared at licensed U.S. compounding pharmacies. Yucca Health contrasts compounded products with branded drugs by noting branded manufacturing is done by Novo Nordisk and that compounded products are not individually evaluated by the FDA.
3. Clinician model and prescribing options
Omzo connects patients with licensed U.S. providers who determine eligibility and may either prescribe compounded medications through a compounding pharmacy or write prescriptions for branded medicines, with providers making the final determination. Omzo also states it is not a medical practice and that clinical services are provided by third party networks of U.S. licensed clinicians. Yucca Health describes a licensed provider review process and says treatment is available only when a licensed clinician determines it is medically appropriate, with providers licensed in all 50 states.
4. Approval speed and shipping
Yucca Health highlights fast online approval, typically within 24 hours, UPS 2-Day Air shipping, and most patients receiving their first shipment within 3 to 5 business days of completing intake. Omzo cites fast, discreet delivery but the specific approval and shipping timeline beyond that phrasing is not supplied in the captured evidence.
Start Omzo intake and check availability
5. Treatment options and support
Both offer semaglutide and tirzepatide programs. Yucca Health highlights tirzepatide as a dual GIP/GLP-1 option and references clinical trial averages when describing expected weight reduction in general research, while noting treatment choice is determined by the assigned provider. Omzo notes personalized GLP-1 care with clinician guidance and includes patient experience language captured on its site. Both emphasize that individual results vary and that outcomes are not guaranteed.
| Criteria | Omzo | Yucca Health |
|---|---|---|
| Semaglutide starting price | Starting at $179 | From $146/month |
| Tirzepatide starting price | Starting at $279 | From $258/month |
| Clinician review | Licensed U.S. providers; third party networks | Licensed providers in all 50 states; physician review |
| Compounded medication note | Compounded drugs are not FDA-approved | Compounded drugs are not FDA-approved |
| Approval and shipping | Fast, discreet delivery noted | Online approval within 24 hours; UPS 2-Day Air; first shipment 3-5 business days |
How to decide: Omzo vs Yucca Health
Use the facts above to match priorities. If lowest monthly cost, rapid online approval, BNPL options, and 2-day shipping are your primary criteria, Yucca Health is positioned for those priorities. If you prioritize clinician-guided plans with providers who may write branded prescriptions for you to fill elsewhere and an emphasis on clinician review networks, Omzo is positioned for those priorities. Remember both platforms offer compounded medications that are not FDA-approved and both say individual results vary and are not guaranteed.
Choose Omzo if…
you want clinician-guided plans reviewed by licensed U.S. providers, the option that providers may prescribe branded medications to be filled at your pharmacy, and a program that highlights clinician judgment and personalized GLP-1 care.
Choose Yucca Health if…
you prioritize lower starting monthly pricing for compounded semaglutide, fast online approvals within 24 hours, UPS 2-Day Air shipping, and Buy Now Pay Later payment options.